Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-04-25 @ 4:05 PM
Study NCT ID:
NCT01227018
Status:
TERMINATED
Last Update Posted:
2014-07-23
First Post:
2010-10-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VICC GI 1016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |